arrow
G

Gavin P Dowling

Royal College of Surgeons in Ireland
H指数:10
被引数:269

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sustainable quality improvement interventions to ensure adequate documentation of chaperone presence in breast clinic: A multi-cycle clinical audit

通过可持续的质量改进干预措施确保乳腺科陪同人员在场记录的充分性:一项多周期临床审计

2026-09-210
OAAI
Laparoscopic-assisted transversus abdominis plane block versus port-site infiltration in appendicectomy: multicentre randomized clinical trial

腹腔镜辅助腹横肌平面阻滞与穿刺点浸润在阑尾切除术中的应用比较:多中心随机临床试验

2026-01-011
PRE
Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies

皮肤免疫相关不良事件及免疫检查点抑制剂对晚期实体器官恶性肿瘤患者的疗效

2025-09-010
OAAI
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study

血浆优先下一代测序在爱尔兰新诊断的晚期非小细胞肺癌患者中的临床获益与成本:PLAN研究

2025-06-170
PRE
PARP Inhibitors in the Neoadjuvant Setting; A Comprehensive Overview of the Rationale for their Use, Past and Ongoing Clinical Trials

PARP抑制剂在辅助治疗前设置中的应用;关于其使用合理性的全面概述及过去和正在进行的临床试验

2025-04-070
OA
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)

早期HER2-positive乳腺癌的新辅助曲妥珠单抗deruxtecan (t-dxd) 与应答导向的确定性治疗: II期研究方案 (三叶草研究)

2024-01-179
OAAI
Nodal positivity in patients with clinically and radiologically node-negative breast cancer treated with neoadjuvant chemotherapy: multicentre collaborative study
2023-12-063
OAAI